Super HDB
Natural health product licensed in Canada
- Licence holder
- Nutrabolt Distribution Canada ULC
- NPN or DIN-HM
- 80041756
- Status
- Inactive licence
- Licence date
- 18 April 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Citrus aurantium L.: La quantité ingérée de p-synéphrine doit être inférieure à 20 mg par dose journalière recommandée. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Citrus aurantium Source : Pelure (fruit) Potency : 30 % Synephrine | 33.33 mg | Not calculated |
| [5R-(5alpha, 9beta, 11E)]-5-amino-11-éthylidène-5 ,6,9,10-tétrahydro-7-méthyl-5 ,9-méthane-cycloocta [b] pyridine-2 (1H)-one Source : Plante entière | 25 mcg | Not calculated |
| [5R-(5alpha, 9beta, 11E)]-5-amino-11-éthylidène-5 ,6,9,10-tétrahydro-7-méthyl-5 ,9-méthane-cycloocta [b] pyridine-2 (1H)-one Source : Huperzine A | 25 mcg | Not calculated |
| 1,3,7-triméthylxanthine Source : Caféine | 158 mg | Not calculated |
| Taraxacum officinale Source : Racine Extraction ratio : 10:1 Dry plant equivalent : 375 mg | 37.5 mg | Not calculated |
| L-Tyrosine Source : N-acétyltyrosine | 121.75 mg | Not calculated |
| 3-Pyridinecarboxamide Source : Niacinamide | 10 mg | Not calculated |
| Rhodiola rosea Source : Racine Potency : 1 % Salidroside | 60 mg | Not calculated |
| Rhodiola rosea Source : Racine Potency : 3 % Rosavin | Not specified | Not calculated |
Non-medicinal ingredients
Silice, Stéarate de magnésium, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | minimum: 1 day ; maximum: 2 days |
Uses authorised in Canada
Caffeine helps (temporarily) to promote alertness and wakefulness, and to enhance cognitive performance. Caffeine helps (temporarily) to relieve fatigue, to promote endurance, and to enhance motor performance. Caffeine is used (temporarily) as a mild diuretic.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are pregnant or breastfeeding; if you have diarrhea, stomach ulcers, or inflammation. Do not consume if you are taking decongestant-containing cold preparations (i.e. phenylephrine or pseudoephedrine), products containing ephedra or ephedrine. Do not use if you have a liver or gall bladder disorder and/or bowel obstruction. If you are taking blood pressure medications (either hypertensives or antihypertensives), thyroid medications, symphathominetrics or monoamine oxide inhibitors (MAOIs), avoid use. If you are taking antidepressant medication, hormone replacement therapy (HRT), or birth control pills, consult a health care practitioner.
Source
Official Health Canada record, licence 80041756
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.